Sernova (STU:PSH) Long-Term Debt : €0.00 Mil (As of Jul. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sernova Long-Term Debt?

Sernova's Long-Term Debt for the quarter that ended in Jul. 2024 was €0.00 Mil.

Sernova Long-Term Debt Historical Data

The historical data trend for Sernova's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Long-Term Debt Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Long-Term Debt

Get a 7-Day Free Trial

0.45

Sernova Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Sernova (STU:PSH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sernova Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Sernova's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (STU:PSH) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany PSH:Germany SVA:Canada

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.